Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

International Federation of Robotics: "Service Robots" Hit Double Digit Growth Worldwide

FRANKFURT AM MAIN, Germany, Nov. 4, 2021 /PRNewswire/ -- The market for professional service robots reached a turnover of6.7 billion U.S. dollars worldwide (sample method) – up 12% in 2020. At the same time, turnover of new consumer service robots grew 16% to4.4 billion U.S. dollars. This is acco...

2021-11-04 21:20 7481

Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting

SUZHOU and SHANGHAI, China, and PALO ALTO, California, Nov. 4, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...

2021-11-04 21:05 1570

I-Mab to Present Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins's Lymphoma at ASH 2021

* Lemzoparlimab is a differentiated CD47 monoclonal antibody discovered by I-Mab and being developed in collaboration with AbbVie * Initial clinical results of lemzoparlimab in combination with rituximab in NHL will be presented at the ASH 2021 Annual Meeting * I-Mab to host a call for inves...

2021-11-04 21:00 1287

Taizhou, China: Building a Famous Chinese Medical City with Efforts

TAIZHOU, China, Nov. 4, 2021 /PRNewswire/ -- Recently, the 12th China (Taizhou) International Medical Expo was held inChina Medical City in Taizhou, China. Starting from the needs of normalized prevention and control of the epidemic, this year's expo made an "online+on-site" integrated exhibition...

2021-11-04 20:16 1086

Medigate Accelerates Expansion to Meet Growing Demand in Asia-Pacific Region

Healthcare's IoT cybersecurity and clinical asset management leader names APAC Regional Director. BROOKLYN, N.Y., Nov. 4, 2021 /PRNewswire/ -- Medigate, Healthcare's Security and Clinical Asset Management leader, today announced its expansion into the Asia-Pacific (APAC) region. Capitalizing on ...

2021-11-04 20:15 1428

Medigate Accelerates Expansion to Meet Growing Demand in Asia-Pacific Region

2021-11-04 20:15 1427

Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases

MELBOURNE, Australia, Nov. 4, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced the publication of two preclinical studie...

2021-11-04 19:30 1306

Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia

FLORENCE, Italy, Nov. 4, 2021 /PRNewswire/ -- The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for the treatment of Acute Myeloid Leukemia (AML). SEL24/MEN1703 is a first-in-class, orally available, dual PIM...

2021-11-04 18:32 1526

Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Treatment for Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, Nov. 4, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...

2021-11-04 17:00 3048

Invitation to the presentation of Elekta's second quarter 2021/22

STOCKHOLM, Nov. 4, 2021 /PRNewswire/ --Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at10:00 a.m. CET on November 25. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day. The company's development will b...

2021-11-04 15:15 2761

Medtecs to showcase PPE and technologies from Taiwan at MEDICA 2021

TAIPEI, Nov. 4, 2021 /PRNewswire/ -- As the COVID-19 crisis persists, global healthcare systems are still under heavy strain due to virus mutation and low vaccination rate. Stable supply of personal protective equipment (PPE) remains crucial at this critical juncture. To showcase the excellent PP...

2021-11-04 14:27 1267

New progress of studies on Lianhua Qingwen's mechanism to fight against SARS-CoV-2

BEIJING, Nov. 4, 2021 /PRNewswire/ -- During the efforts to prevent and control the epidemic, "3 medicines and 3 prescriptions" are selected from traditional Chinese medicine inChina, including the representative medicine "Lianhua Qingwen ", produced by Yiling pharmaceutical, which has been widely...

2021-11-04 12:56 2086

Envirotainer Opens New station in Guangzhou, China

STOCKHOLM, Nov. 4, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that they are opening a new station inGuangzhou, China to provide ground handling of container types RKN e1 and RAP e2. Envirot...

2021-11-04 10:39 1576

Dymax Releases First-of-Kind Adhesives for Medical Wearables Assembly

SINGAPORE, Nov. 4, 2021 /PRNewswire/ -- Dymax , leading global manufacturer of rapid-curing materials and equipment, introduces the 2000-MW series of light-curable adhesives specifically developed to address customer requirements and market trends within the rapidly evolving m...

2021-11-04 10:00 2028

Dymax Releases First-of-Kind Adhesives for Medical Wearables Assembly

Medtecs to showcase PPE and technologies from Taiwan at MEDICA 2021

TAIPEI, Nov. 3, 2021 /PRNewswire/ -- It is now half-way through autumn and the COVID-19 pandemic still persists. The global death toll has reached over 5 million yet only 45.4% of the global population has received at least one dose of vaccine. To make matters worse, a new subvariant of the virus...

2021-11-04 09:56 1576

Medtecs to showcase PPE and technologies from Taiwan at MEDICA 2021

Kazia Enrols First Patient to EVT801 Phase I Clinical Trial

SYDNEY, Nov. 4, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that it has commenced enrolment to a phase I clinical trial of EVT801, an investigational cancer therapy that Kazia licensed from Evotec S...

2021-11-04 08:38 2840

Sensational artemisinin-piperaquine for treatment of COVID-19 in prospect

GUANGZHOU, China, Nov. 3, 2021 /PRNewswire/ -- Artequick artemisinin and piperaquine tablets have once again become buzzwords across the globe, as most recently, their effectiveness in treating COVID-19 was hotly debated by live streamers on overseas social media and we media platforms. These dru...

2021-11-03 22:42 1798

Sensational artemisinin-piperaquine for treatment of COVID-19 in prospect

Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

- Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities inNew Zealand - All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe GAITHERSBURG, Md., Nov. 3, 20...

2021-11-03 22:14 2546

Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX

AUSTIN, Texas, Nov. 3, 2021 /PRNewswire/ -- OncoTEX Inc. (OncoTEX), a US oncology company and member of The iQ Group Global portfolio, is pleased to announce it has acquired a gold compound platform technology that induces the body's immune system to destroy cancer cells. The technology has been...

2021-11-03 22:00 1431

TransThera Receives Fast Track Designation from FDA for its Core Product TT-00420 to Treat Cholangiocarcinoma

NANJING, China, Nov. 3, 2021 /PRNewswire/ -- TransThera Sciences (Nanjing) Inc., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative small molecule drug therapies for oncology, inflammatory and cardiovascular diseases, announced that the U.S. Food and Drug...

2021-11-03 22:00 1403

1 ... 320 321 322323324 325 326 ... 577